CRO

Gallus inks manufacturing deal with Genzyme; Medidata lures Daiichi Sankyo;

> Vivus ($VVUS) has selected Sanofi's ($SNY) contract manufacturing unit to produce its recently approved Spedra. Article

> Clinical trial software outfit Medidata ($MDSO) has signed a deal with Japanese pharma giant Daiichi Sankyo. More

> Gallus BioPharmaceuticals has inked a multi-year deal with Genzyme to develop and manufacture a new protein therapy. Story

> Scientific software contractor Accelrys ($ACCL) is lopping off 80 jobs amid flattening revenue. News

> CRO Novum has recruited PRACS Institute veteran Alan Copa to serve as vice president and lead clinical expansion. Announcement